A lack of diversity in genomic studies for dementia could limit the effectiveness of targeted therapies across underrepresented populations, finds research by UCL experts.
This article was originally published on MedicalXpress.com
A lack of diversity in genomic studies for dementia could limit the effectiveness of targeted therapies across underrepresented populations, finds research by UCL experts.
This article was originally published on MedicalXpress.com
© 2024 SimplyWell.ca